| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 2,080 | $110 | $227.2K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 2,080 | $80 | $168.2K |
| J3262 | Injection, tocilizumab, 1 mg | 27,360 | $10 | $136.8K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 9,250 | $10 | $101.8K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 3,420 | $30 | $88.9K |
| J0897 | Injection, denosumab, 1 mg | 2,640 | $20 | $50.2K |
| 20611 | In this procedure, the provider inserts a needle through the skin of a patient and into a major joint or bursa, typically the shoulder, hip, knee, or subacromial bursa, and then uses the syringe… | 490 | $90 | $42.5K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 320 | $120 | $39.2K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 640 | $60 | $37.6K |
| 86235 | The lab analyst performs an assay to evaluate the patient’s serum for each antibody to an extractable nuclear antigen, also called ENA. Types of ENA antibodies include anti ribonuclear protein,… | 1,970 | $20 | $35.4K |